Skip to content

Stroke Education Intervention Trial - Pilot

AVAIL interVention Trial (Adherence Evaluation After Ischemic Stroke - Longitudinal): Pilot Protocol

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01115660
Acronym
AVAIL II
Enrollment
30
Registered
2010-05-04
Start date
2010-01-31
Completion date
2011-06-30
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhage, Ischemic Stroke, Transient Ischemic Attack

Keywords

stroke, patient education, medication adherence

Brief summary

The objectives of the trial of a medication-coach program for patients with stroke or transient ischemic attack are to pilot test the study design, the intervention components and the data collection forms and refine them for a larger trial whose goal will be to improve long-term adherence to stroke prevention medications.

Interventions

call by medication coach 2 weeks after hospital discharge

Sponsors

Wake Forest University Health Sciences
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients at Wake Forest University Baptist Medical Center (WFUBMC) over age 18 * Diagnosed with acute ischemic stroke, transient ischemic attack or intracranial hemorrhage * provide consent to participate

Exclusion criteria

* discharged to nursing home, acute rehabilitation center, inpatient hospice, or other acute hospital * homeless * non-English speakers * patient and proxy unable to participate in telephone conversation

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Intervention (Ability to Reach Patients at 3 Months)3 monthsNumber of patients contacted at 3 months

Secondary

MeasureTime frameDescription
Follow up Appointment With MD3 monthsFollow up appointment with primary care provider since stroke

Countries

United States

Participant flow

Recruitment details

Enrolled patients in 2010 at Wake Forest Baptist Medical Center

Pre-assignment details

Patients assigned to intervention arm and control arm, consecutively.

Participants by arm

ArmCount
Stroke Education
Patients in this arm receive a telephone call by a medication coach who reviews their condition and importance of adherence to medication regimen.
20
Control Arm
Patients received standard discharge counseling but no 2-week follow-up call.
10
Total30

Baseline characteristics

CharacteristicStroke EducationTotalControl Arm
Age, Continuous
Median Age
61 years
INTER_QUARTILE_RANGE 7
61 years
INTER_QUARTILE_RANGE 8
59 years
INTER_QUARTILE_RANGE 10
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
10 Participants13 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
White
9 Participants16 Participants7 Participants
Region of Enrollment
United States
20 participants30 participants10 participants
Sex: Female, Male
Female
8 Participants12 Participants4 Participants
Sex: Female, Male
Male
12 Participants18 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Feasibility of Intervention (Ability to Reach Patients at 3 Months)

Number of patients contacted at 3 months

Time frame: 3 months

Population: All eligible patients who also were available at 3 months for post-intervention follow-up call.

ArmMeasureValue (NUMBER)
Stroke EducationFeasibility of Intervention (Ability to Reach Patients at 3 Months)16 number of patients contacted
ControlFeasibility of Intervention (Ability to Reach Patients at 3 Months)10 number of patients contacted
Secondary

Follow up Appointment With MD

Follow up appointment with primary care provider since stroke

Time frame: 3 months

Population: Patients who were contacted at 3 months

ArmMeasureValue (NUMBER)
Stroke EducationFollow up Appointment With MD15 participants
ControlFollow up Appointment With MD7 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026